Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Patient Interview: Living With Tardive Dyskinesia

Listen to Leslie, a patient with TD for the past 10 years, describe her experience with the disease from diagnosis to current impact on her daily life.
person default
Joseph P. McEvoy, MD
Released: September 28, 2022

Patient Interview: Living With Tardive Dyskinesia

In this podcast episode on tardive dyskinesia (TD), Joseph P. McEvoy, MD, interviews Leslie, a patient who was diagnosed with TD 10 years ago. She describes her journey to an accurate diagnosis, the impact that TD has on her daily life, and her advice for patients and providers affected by TD.

Information on this Educational Activity




Joseph P. McEvoy, MD

Psychiatry and Health Behavior
Augusta University
Augusta, Georgia

Joseph P. McEvoy, MD: /advisor/speaker: Clarion, Neurocrine; researcher: Alkermes, Biogen, Boehringer Ingelheim, Millennium, National Institute of Diabetes, National Institute of Mental Health, Otsuka.

Program Medium

This program has been made available online.


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Neurocrine Biosciences, Inc.

Related Content

Two expert faculty have a conversation about their approaches to managing Parkinson’s disease psychosis in clinical practice, from Clinical Care Options (CCO)

Marwan Sabbagh, MD, FAAN Marta San Luciano, MD, MS, FAAN Released: November 15, 2022

Discussion of strategies for symptom management and improvement in bipolar depression, from Clinical Care Options (CCO)

Joseph F. Goldberg, MD Roger McIntyre, MD, FRCPC Released: November 2, 2022

Experts discuss aspects of tardive dyskinesia management from identification to pharmacologic options, from Clinical Care Options (CCO)

Robert O. Cotes, MD Jonathan M. Meyer, MD Released: October 28, 2022

A discussion of VMAT2 inhibitors and other pharmacologic options for tardive dyskinesia management, from Clinical Care Options (CCO)

person default Diana O. Perkins, MD, MPH person default Rajiv Tandon, MD Released: October 17, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings